Company / Shareholders' Equity
ACCENDRA HEALTH INC/VA/ Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$461.0M
FY2025
5-year range
-$461.0M / $966.7M
FY2021-FY2025
Trend
-178.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
ACCENDRA HEALTH INC/VA/ reports negative total equity of -$461M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$461M in FY2025.
Declined from $945M to -$461M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ACCENDRA HEALTH INC/VA/'s shareholders' equity has declined for 3 consecutive years.
- In FY2025, shareholders' equity decreased 178.6% year-over-year.
- Peak shareholders' equity was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$461.0M | -178.6% |
| FY2024 | $586.4M | -38.0% |
| FY2023 | $945.3M | -2.2% |
| FY2022 | $966.7M | +109.2% |
| FY2021 | $462.2M | -35.1% |
| FY2020 | $712.1M | +37.4% |
| FY2019 | $518.4M | +0.0% |
| FY2018 | $518.4M | -48.9% |
| FY2017 | $1.0B | +5.8% |
| FY2016 | $960.0M | -3.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026